Vivos Therapeutics Signs 12-Part Media Series With New to The Street | Sleep Tech Growth | NewsOut

Healthcare and medtech investors: Vivos Therapeutics, a medical technology company focused on innovative treatments for breathing and sleep disorders, has signed a 12-part media series agreement with New to The Street, a long-running business television and digital media platform.

Reporting from the New York Stock Exchange, Jane King explains that the 12-month series will expand Vivos’ visibility among investors, healthcare professionals, and strategic partners through a multi-channel strategy spanning national television, digital platforms, social media, outdoor advertising, and live investor engagement.

#VivosTherapeutics
#SleepTechnology
#MedicalDevices
#HealthcareInnovation
#BreathingDisorders
#MedTech
#NewToTheStreet
#MediaSeries
#InvestorAwareness
#HealthcareInvesting
#JaneKing
#NewsOut
#NYSE